Placental 11β-Hydroxysteroid Dehydrogenase Type 2 is Reduced in Pregnancies Complicated with Idiopathic Intrauterine Growth Restriction: Evidence That This is Associated With an Attenuated Ratio of Cortisone to Cortisol in the Umbilical Artery

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Placenta

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PLACENTA.2007.10.010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth in utero and coronary heart disease.

  2009cited by this paper
• Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.

  2007cited by this paper
• Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models?

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptor δ Suppresses 11β-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Human Placental Trophoblast Cells

  2005cited by this paper
• Cadmium reduces 11-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells

  2005cited by this paper
• Glucocorticoids stimulate the expression of 11beta-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells.

  2004cited by this paper
• Current Concepts in Intrauterine Growth Restriction

  2004cited by this paper
• Fetal growth restriction: a workshop report.

  2004cited by this paper
• Placental 11β-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants

  2003cited by this paper
• Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies.

  2003cited by this paper
• Placental insufficiency and its consequences.

  2003cited by this paper
• Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma.

  2002cited by this paper
• The Expression of 11β-Hydroxysteroid Dehydrogenase Type 2 Is Induced during Trophoblast Differentiation: Effects of Hypoxia

  2002cited by this paper
• Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms.

  2001cited by this paper
• Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.

  2001cited by this paper
• Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women.

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Decreased Gene Expression of 11�-Hydroxysteroid Dehydrogenase Type 2 and 15-Hydroxyprostaglandin Dehydrogenase in Human Placenta of Patients

  2000cited by this paper
• Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action.

  1999cited by this paper
• Expression of the 11beta-hydroxysteroid dehydrogenase types 1 and 2 proteins in human and baboon placental syncytiotrophoblast.

  1999cited by this paper
• Prostaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells.

  1999cited by this paper
• CURRENT CONCEPTS OF FETAL GROWTH RESTRICTION: PART I. CAUSES, CLASSIFICATION, AND PATHOPHYSIOLOGY

  1998cited by this paper
• 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.

  1998cited by this paper
• Placental 11β-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic pregnancies

  1998cited by this paper
• Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids.

  1997cited by this paper
• Variation in placental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight

  1997cited by this paper
• Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure

  1997cited by this paper
• Apparent mineralocorticoid excess due to 11β‐hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation

  1996cited by this paper
• Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta.

  1995cited by this paper
• Co-expression of two distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine placenta

  1995cited by this paper
• Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis.

  1995cited by this paper
• Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation.

  1995cited by this paper
• Glucocorticoids and small babies.

  1994cited by this paper
• Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues.

  1994cited by this paper
• Glucocorticoid exposure in utero: new model for adult hypertension.

  1993cited by this paper
• Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses.

  1993cited by this paper
• Birth Weight Percentiles by Gestational Age in Canada

  1993cited by this paper
• Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development.

  1992cited by this paper
• In utero analysis of fetal growth: a sonographic weight standard.

  1991cited by this paper
• Effect of estrogen on the metabolism of cortisol and cortisone in the baboon fetus at midgestation.

  1988cited by this paper
• Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

  1988cited by this paper
• The maternal-fetal cortisol gradient during pregnancy and at delivery.

  1977cited by this paper
• Cortisol levels in maternal venous and umbilical cord arterial and venous serum at vaginal delivery.

  1976cited by this paper
• FETAL PLASMA STEROIDS IN RELATION TO PARTURITION

  1974cited by this paper
• The role of cortisol in human parturition.

  1973cited by this paper
• PLASMA CORTISONE AND CORTISOL LEVELS AT BIRTH AND DURING THE NEONATAL PERIOD.

  1965cited by this paper
• Ratio cortisone/cortisol in mother and infant at birth.

  1962cited by this paper

• In utero adverse exposures and cardiovascular health in the offspring

  2026cites this paper
• Maternal‐Fetal Impact of Respiratory Viral Infections: Immune Mechanisms and Clinical Outcomes

  2026cites this paper
• Autism Pathoetiology and Pathophysiology: Roles of STAT3 and NF-κB Dimer Interactions in Regulating the Mitochondrial Melatonergic Pathway in Placental, CNS, and Systemic Cells.

  2026cites this paper
• Late gestation heat stress induces inflammation and impacts nutrient transfer signature in the placenta of dairy cows.

  2025cites this paper
• Maternal stress and fetoplacental cortisol regulation in small‐for‐gestational‐age newborns

  2025cites this paper
• Linking Pregnancy- and Birth-Related Risk Factors to a Multivariate Fusion of Child Cortical Structure

  2025cites this paper
• Linking pregnancy- and birth-related risk factors to a multivariate fusion of child cortical structure

  2025cites this paper
• Perinatal glucocorticoid sensitivity in the preterm newborn: molecular mechanisms, endogenous determinants, and clinical implications

  2025cites this paper
• TFEB controls syncytiotrophoblast formation and hormone production in placenta

  2024cites this paper
• DNA methylation landscape in pregnancy-induced hypertension: progress and challenges

  2024cites this paper
• Exploring Maternal Diet-Epigenetic-Gut Microbiome Crosstalk as an Intervention Strategy to Counter Early Obesity Programming

  2024cites this paper
• Gene and Protein Expression of Placental Nutrient-Stress Sensor Proteins in Fetal Growth Restriction

  2024cites this paper
• Fetal Glucocorticoid Mediates the Association between Prenatal Per- and Polyfluoroalkyl Substance Exposure and Neonatal Growth Index: Evidence from a Birth Cohort Study.

  2023cites this paper
• Direct inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by per- and polyfluoroalkyl substances: structure-activity relationship and in silico docking analysis.

  2023cites this paper
• Cadmium induces placental glucocorticoid barrier damage by suppressing the cAMP/PKA/Sp1 pathway and the protective role of taurine.

  2022cites this paper
• Environmental chemicals and adverse pregnancy outcomes: Placenta as a target and possible driver of pre- and postnatal effects

  2022cites this paper
• Prenatal Environment and Neurodevelopmental Disorders

  2022cites this paper
• Maternal Plasma Choline during Gestation and Small for Gestational Age Infants

  2022cites this paper
• Associations between maternal awakening salivary cortisol levels in mid-pregnancy and adverse birth outcomes

  2022cites this paper
• Fetal Origins of Adult Health and Disease

  2021cites this paper
• Non-invasive fetal electrocardiography, electrohysterography and speckle-tracking echocardiography in the second trimester: study protocol of a longitudinal prospective cohort study (BEATS-study)

  2021cites this paper
• Metabolic Disease Programming: From Mitochondria to Epigenetics, Glucocorticoid Signalling and Beyond

  2021cites this paper
• The impact of prenatal stressful life events on adverse birth outcomes: A systematic review and meta-analysis.

  2021cites this paper
• The impact of intrauterine growth restriction on cytochrome P450 enzyme expression and activity.

  2020cites this paper
• Genomic Imbalances in the Placenta Contribute to Poor Fetal Growth

  2020cites this paper
• Genomic imbalances in the placenta are associated with poor fetal growth

  2020cites this paper
• A bibliometric analysis of Intrauterine Growth Restriction research.

  2020cites this paper
• Sex steroids, IGF-I, and vascular morphology from birth to adulthood in individuals born small for gestational age

  2020cites this paper
• Progesterone-regulated Hsd11b2 as a barrier to balance mouse uterine corticosterone.

  2020cites this paper
• Altered umbilical sex steroids in preterm infants born small for gestational age

  2020cites this paper
• Lipopolysaccharide Downregulates 11β-Hydroxysteroid Dehydrogenase 2 Expression through Inhibiting Peroxisome Proliferator–Activated Receptor-γ in Placental Trophoblasts

  2019cites this paper
• Stress, female reproduction and pregnancy.

  2019cites this paper
• Postoperative pain in small-for-gestational age infants after hernia repair, orchidopexy and urethral reconstruction surgery: A pilot study.

  2019cites this paper
• Cortisol metabolism in pregnancies with small for gestational age neonates

  2019cites this paper
• Associations between in utero exposure to polybrominated diphenyl ethers, pathophysiological state of fetal growth and placental DNA methylation changes.

  2019cites this paper
• Placental concentrations of essential, toxic, and understudied metals and relationships with birth outcomes in Chattanooga, TN

  2019cites this paper
• Mechanisms for establishment of the placental glucocorticoid barrier, a guard for life

  2018cites this paper
• Prenatal stress, the placenta and maternal microbial transmission; implications for health and disease

  2018cites this paper
• Placental FKBP51 mediates a link between second trimester maternal anxiety and birthweight in female infants

  2018cites this paper
• Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction.

  2018cites this paper
• Placental tissue metabolome analysis by GC-MS: Oven-drying is a viable sample preparation method

  2018cites this paper
• The effect of body and mind stress-releasing techniques on the breastfeeding of full-term babies; a critical analysis of published interventional studies

  2018cites this paper
• Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications

  2018cites this paper
• HSD11B2, RUNX3, and LINE-1 Methylation in Placental DNA of Hypertensive Disorders of Pregnancy Patients

  2017cites this paper
• Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells

  2017cites this paper
• Maternal growth restriction and stress exposure in rats differentially alters expression of components of the placental glucocorticoid barrier and nutrient transporters.

  2017cites this paper
• Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond

  2017cites this paper
• 11 beta‐hydroxysteroid dehydrogenase 2 promoter methylation is associated with placental protein expression in small for gestational age newborns

  2017cites this paper
• Inhibition of 11&bgr;‐hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole

  2017cites this paper
• Diámetro transversal del timo fetal en el segundo trimestre del embarazo en mujeres que posteriormente desarrollan preeclampsia

  2017cites this paper
• Effects of prenatal maternal stress on serotonin and fetal development.

  2016cites this paper
• The formation and transformation of hormones in maternal, placental and fetal compartments: biological implications

  2016cites this paper
• Inhibition of placental 11beta-hydroxysteroid dehydrogenase type 2 by lead.

  2016cites this paper
• The Placenta and Developmental Origins of Health and Disease

  2016cites this paper
• Prenatal maternal stress and child ADHD symptoms in early childhood

  2015cites this paper
• Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone

  2015cites this paper
• The Role of Placental 11-Beta Hydroxysteroid Dehydrogenase Type 1 and Type 2 Methylation on Gene Expression and Infant Birth Weight1

  2015cites this paper
• Fetal thymus size in human pregnancies reveals inverse association with regulatory T cell frequencies in cord blood.

  2015cites this paper
• Placental Endocrine Function and Hormone Action

  2015cites this paper
• The placenta: a multifaceted, transient organ

  2015cites this paper
• Placental 11β-Hydroxysteroid dehydrogenase type 2 expression: Correlations with birth weight and placental metal concentrations.

  2015cites this paper
• Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.

  2015cites this paper
• Reduced expression of 11β-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARγ but increased PPARα expression.

  2014cites this paper
• Late preterm birth, post-term birth, and abnormal fetal growth as risk factors for severe mental disorders from early to late adulthood

  2014cites this paper
• Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies.

  2014influential citation
• Histoquímica e morfometria da placenta de ratas tratadas com dexametasona

  2014cites this paper
• Comparison between placental gene expression of 11β‐hydroxysteroid dehydrogenases and infantile growth at 10 months of age

  2014cites this paper
• Effects of maternal stress and obesity on human feto-placental glucocorticoid exposure

  2014cites this paper
• The association between the acute psychobiological stress response in second trimester pregnant women, amniotic fluid glucocorticoids, and neonatal birth outcome.

  2014cites this paper
• Is cortisol the underlying mediator of prenatal risk factors associated with autism spectrum disorders

  2014cites this paper
• Activation of endocrine-related gene expression in placental choriocarcinoma cell lines following DNA methylation knock-down.

  2014cites this paper
• Glucocorticoid programming of the fetal male hippocampal epigenome.

  2013cites this paper
• Fetal programming of adult arterial hypertension: cellular and molecular mechanisms

  2013cites this paper
• Effects of antenatal synthetic glucocorticoid on glucocorticoid receptor binding, DNA methylation, and genome-wide mRNA levels in the fetal male hippocampus.

  2013cites this paper
• Early Onset Pre-Eclampsia Is Associated with Altered DNA Methylation of Cortisol-Signalling and Steroidogenic Genes in the Placenta

  2013cites this paper
• Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction

  2013cites this paper
• Metabolic and hormonal profiles in cord blood of idiopathic intrauterine growth-restricted newborns and associated maternal metabolic disorders

  2013cites this paper
• The ERK1/2 Signaling Pathway Regulates 11beta-Hydroxysteroid Dehydrogenase Type 2 Expression in Human Trophoblast Cells Through a Transcriptional Mechanism1

  2013cites this paper
• Combined quantification of corticotropin-releasing hormone, cortisol-to-cortisone ratio and progesterone by liquid chromatography-Tandem mass spectrometry in placental tissue.

  2013cites this paper
• 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

  2013cites this paper
• Programación Fetal "in utero" y su impacto en la salud del adulto

  2012cites this paper
• Placental 11b-hydroxysteroid dehydrogenase expression and birth weight in Hamilton County, TN

  2012cites this paper
• Sequelae of Fetal Growth Restriction

  2012cites this paper
• Developmental Origins of Adult Health and Disease

  2012cites this paper
• Programación Fetal in utero y su impacto en la salud del adulto

  2012cites this paper
• Differential expression of placental 11β-hydroxysteroid dehydrogenases in pregnant women with diet-treated gestational diabetes mellitus.

  2012cites this paper
• Association between maternal blood cadmium during pregnancy and birth weight and the risk of fetal growth restriction: the EDEN mother-child cohort study.

  2012cites this paper
• Corticotropin-releasing hormone stimulates expression of leptin, 11beta-HSD2 and syncytin-1 in primary human trophoblasts

  2012cites this paper
• DNA methylation of stress-related genes and LINE-1 repetitive elements across the healthy human placenta.

  2012cites this paper
• Linking prenatal maternal adversity to developmental outcomes in infants: The role of epigenetic pathways

  2012cites this paper
• Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.

  2012cites this paper
• Glucocorticoids: Biochemical Group That Play Key Role in Fetal Programming of Adult Disease

  2012cites this paper
• Caffeine Reduces 11β-Hydroxysteroid Dehydrogenase Type 2 Expression in Human Trophoblast Cells through the Adenosine A2B Receptor

  2012cites this paper
• [In utero fetal programming and its impact on health in adulthood].

  2012cites this paper
• Maternal antioxidant blocks programmed cardiovascular and behavioural stress responses in adult mice.

  2011cites this paper
• Glucocorticoids in pregnancy.

  2011cites this paper
• Dexamethasone stimulates the expression of leptin and 11β-HSD2 in primary human placental trophoblastic cells.

  2011cites this paper
• Prenatal exposure to LPS leads to long-lasting physiological consequences in male offspring.

  2011cites this paper
• Stress regulating systems and their role for an intrauterine origin of diseases

  2011cites this paper
• Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

  2011cites this paper